Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.

ABSTRACT: Takotsubo cardiomyopathy (TTS) has become a recognised clinical entity since the Japanese scientist Sato first described it in 1990. Despite an increasing number of confirmed cases, especially during the COVID-19 pandemic, its pathophysiology remains incompletely understood, and decision-making differs in the diagnosis and treatment. In addition, it is not evident whether a significant increase in TTS is due to better understanding among practitioners and widespread access to coronary angiography, or if it is a reflection of an actual increase in incidence. We analysed a series of international research studies from 1990 to 2021. Beyond epidemiology and clinical presentation, we evaluated and summarised fundamental knowledge about various predisposing factors, with particular attention to

SUBMITTER: Bairashevskaia AV 

PROVIDER: S-EPMC8913320 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature